Dr. Connie Lehman, MD, PhD, has dedicated her life’s work to the advancement of breast imaging and the early identification of cancer. With over 250 peer-reviewed scientific publications and decades of research spanning computer aided diagnosis, deep learning, artificial intelligence, density assessment, predictive risk models, effective imaging workflow and risk-based triage, Dr. Lehman is one of the industry’s foremost experts. The success of her research and collaboration with MIT and Mass General Brigham fueled her desire to change the way women are screened for breast cancer around the globe. She is currently Chief of Breast Imaging at Massachusetts General Hospital.
The implications of swollen lymph nodes following COVID-19 vaccination
Advanced planning can support our patients to feel confident and safe to receive their vaccinations as well as undergo recommended imaging in their usual care.